Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Immunoglobulin g (human)
Drug ID BADD_D01145
Description Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion exchange chromatography. IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. IgG subclasses are fully represented in the following proportions: 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4. IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders.
Indications and Usage IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. These indications includes idiopathic thrombocytopenic purpura, Kawasaki disease, hypogammaglobulinemia, B cell chronic lymphocytic leukemia, bone marrow transplant complications, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), multiple sclerosis, rheumatoid arthritis, myesthenia gravis, Wiskott–Aldrich syndrome and inflammatory skin diseases.
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB00028
KEGG ID Not Available
MeSH ID D007074
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 44206-451; 44206-457; 69800-0250; 64208-8234; 44206-438; 64208-8235; 44206-454; 44206-452; 44206-456; 44206-436; 44206-437; 44206-439; 44206-455; 44206-458
UNII Not Available
Synonyms Immunoglobulin G | IgG | IgG Antibody | Antibody, IgG | Gamma Globulin, 7S | 7S Gamma Globulin | IgG2A | IgG2B | Polyglobin | Allerglobuline | IgG(T) | Immunoglobulin GT | GT, Immunoglobulin | IgG1 | IgG4 | IgG2 | IgG3
Chemical Information
Molecular Formula Not Available
CAS Registry Number 308067-58-5
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Acute respiratory distress syndrome24.03.02.034; 10.02.01.067; 22.01.03.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anxiety19.06.02.002--
Apnoea22.02.01.001--
Asthma22.03.01.002; 10.01.03.010--Not Available
Blood pressure systolic increased13.14.03.006--Not Available
Bronchospasm10.01.03.012; 22.03.01.004--
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cardiac arrest02.03.04.001--
Cerebrovascular disorder24.03.05.002; 17.08.02.002--Not Available
Chest pain08.01.08.002; 02.02.02.011; 22.12.02.003--Not Available
Chills15.05.03.016; 08.01.09.001--
Circulatory collapse24.06.02.001--Not Available
Coma17.02.09.001--Not Available
Coombs direct test positive13.01.01.001--Not Available
Cough22.02.03.001--
Cyanosis23.06.04.005; 02.11.04.004; 24.03.01.007; 22.02.02.007--
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Dermatitis bullous23.03.01.002--
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dyspnoea02.11.05.003; 22.02.01.004--
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Fatigue08.01.01.002--
Haematoma24.07.01.001--
Haemolysis01.06.04.002--
The 1th Page    1 2 3    Next   Last    Total 3 Pages